Voyager Therapeutics, Inc.

VYGR | NASDAQ | 0 Followers
$3.11 +5.07% $0.15
Follow
Loading...

Profile

Voyager Therapeutics, Inc. (VYGR) is a biotechnology company focused on developing therapeutic products for neurological disorders. With a deep understanding of the brain and nervous system, Voyager Therapeutics aims to transform the treatment of these complex diseases through gene therapy. Their research focuses on utilizing adeno-associated viruses to deliver therapeutic genes to the brain and restore normal functions. The company seeks to provide new possibilities for patients with neurodegenerative diseases. Voyager Therapeutics, Inc. (VYGR) shares could be suitable for investors who wish to support innovative developments in treatment approaches within the field of neurology and contribute to improving the quality of life for patients.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade